Literature DB >> 2438844

Expression of Japanese encephalitis virus antigens in Escherichia coli.

P W Mason, P C McAda, J M Dalrymple, M J Fournier, T L Mason.   

Abstract

The expression of Japanese encephalitis virus (JE) cDNA in Escherichia coli has been used to study the functional organization of the viral genome. JE protein coding sequences were expressed in E. coli by subcloning random fragments of cloned cDNA (P.C. McAda, P.W. Mason, C.S. Schmaljohn, J.M. Dalrymple, T.L. Mason, and M.J. Fournier, 1987, Virology 158, 348-360) into the bacteriophage lambda gt11 expression vector. Over 120 lambda gt11 recombinants expressing viral protein sequences as beta-galactosidase fusion proteins were identified immunologically with monoclonal antibodies (MAbs) and polyclonal hyperimmune mouse ascites fluid (HMAF). This expression and immunological detection strategy has been used to (1) map viral protein coding sequences to the JE genome; (2) demonstrate that contiguous viral protein coding regions can be expressed as single polypeptides in E. coli, providing functional confirmation for a long viral open reading frame; (3) localize important antigenic domains within the envelope protein E; and (4) identify in JE-infected cells a form of the glycosylated nonstructural protein NS1 that contains a hydrophobic C-terminal extension encoded by portions of the "ns2a" region of the JE genome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438844     DOI: 10.1016/0042-6822(87)90208-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens.

Authors:  Diana Ludolfs; Stefan Schilling; Jan Altenschmidt; Herbert Schmitz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

Authors:  T J Chambers; A Grakoui; C M Rice
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  A novel complex formed between the flavivirus E and NS1 proteins: analysis of its structure and function.

Authors:  B J Blitvich; J S Mackenzie; R J Coelen; M J Howard; R A Hall
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Proteolytic disruption of laminin-integrin complexes on muscle cells during synapse formation.

Authors:  M J Anderson; Z Q Shi; S L Zackson
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  NS1 protein secretion during the acute phase of West Nile virus infection.

Authors:  Joanne Macdonald; Jessica Tonry; Roy A Hall; Brent Williams; Gustavo Palacios; Mundrigi S Ashok; Omar Jabado; David Clark; Robert B Tesh; Thomas Briese; W Ian Lipkin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  Zika virus: An emerging flavivirus.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

8.  NS1' colocalizes with NS1 and can substitute for NS1 in West Nile virus replication.

Authors:  Lucy B Young; Ezequiel Balmori Melian; Alexander A Khromykh
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Preparation of Japanese encephalitis virus nonstructural protein NS1 obtained from culture fluid of JEV-infected Vero cells.

Authors:  T Lee; K Watanabe; C Aizawa; A Nomoto; H Hashimoto
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.

Authors:  Zijiang Zhao; Takaji Wakita; Kotaro Yasui
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.